44 related articles for article (PubMed ID: 8209448)
1. [Syndrome of chronic overdose of insulin and hypoglycemic sulfanilamide drugs].
Arzumetova DS; Saburenko MB; Shagazatova BKh; Zabikhodzhaeva GZ
Klin Med (Mosk); 1989 Apr; 67(4):99-101. PubMed ID: 2666739
[TBL] [Abstract][Full Text] [Related]
2. [The use of the alpha-glucosidase inhibitor acarbose for the treatment of type-2 diabetes mellitus in secondary sulfanilamide resistance].
Gendeleka GF
Lik Sprava; 1997; (6):105-7. PubMed ID: 9589946
[TBL] [Abstract][Full Text] [Related]
3. [Use of hypoglycemic sulfanilamide preparations in surgical injuries and operative interventions in diabetic patients].
Iatsenko VN
Khirurgiia (Mosk); 1981 Jun; (6):38-43. PubMed ID: 7019547
[No Abstract] [Full Text] [Related]
4. Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes.
Westphal SA; Palumbo PJ
Arch Intern Med; 2003 Aug 11-25; 163(15):1783-5; discussion 1785. PubMed ID: 12912711
[No Abstract] [Full Text] [Related]
5. [The sulfanilamide resistance of patients with type-2 diabetes mellitus].
Gendeleka GF; Lakiza VV
Lik Sprava; 1993 Apr; (4):51-6. PubMed ID: 8209448
[No Abstract] [Full Text] [Related]
6. [Which treatment can be proposed to a diabetic patient presenting with secondary failure of oral antidiabetics?].
Blanc MH; Galtier-Dereure F; Parer-Richard C; Bringer J; Jaffiol C
Rev Med Suisse Romande; 1993 Nov; 113(11):955-61. PubMed ID: 8272722
[No Abstract] [Full Text] [Related]
7. [Sulfonylurea and alpha-glucosidase inhibitor].
Iijima T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():459-63. PubMed ID: 12387034
[No Abstract] [Full Text] [Related]
8. [Treatment of type 2 diabetes. Early detection of secondary oral treatment failure is important].
Clauson P; Efendic S
Lakartidningen; 1999 Jan; 96(3):176-81. PubMed ID: 9951232
[TBL] [Abstract][Full Text] [Related]
9. [Glitazone--a new drug for type 2 diabetes].
Toyota T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():422-8. PubMed ID: 12387028
[No Abstract] [Full Text] [Related]
10. The continuation of oral medications with the initiation of insulin therapy in type 2 diabetes: a review of the evidence.
McFarland MS; Knight TN; Brown A; Thomas J
South Med J; 2010 Jan; 103(1):58-65. PubMed ID: 19996858
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacologic profile of oral antidiabetic agents].
Okubo M; Yamane K; Kohno N
Nihon Rinsho; 2002 Sep; 60 Suppl 9():310-6. PubMed ID: 12387011
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
